When AN2 Therapeutics, Inc. reports, what it reported each quarter, and how the stock took the results.
23 quarters. Mar 31, 2021 to Sep 30, 2026. mixed units.
Mar 16, after the close
Tue, Mar 16, 2027in 117 days
Projected from its last 8 releases. The company has not named the day yet.
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
AN2 Therapeutics, Inc. · CIK 1880438 · Engraved from SEC EDGAR
| Q3 2026 | Sep 30, 2026 | Nov 6, 2026 · after-hours | Nov 9, 2026 | 40 d | 10-Q | — | — | -$0.17 | — |
|---|
| Q2 2026 | Jun 30, 2026 | Aug 11, 2026 · after-hours | Aug 11, 2026 | 42 d | 10-Q | — | — | -$0.18 | +6.5% |
|---|
| Q1 2026 | Mar 31, 2026 | May 11, 2026 · after-hours | May 11, 2026 | 41 d | 10-Q | — | — | -$0.29 | 9.3% |
|---|
| FY 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 17, 2026 · after-hours | Mar 17, 2026 | 76 d | 10-K | — | — | — | 7.6% | |
| Q3 2025 | Sep 30, 2025 | Nov 12, 2025 · after-hours | Nov 12, 2025 | 43 d | 10-Q | — | — | -$0.31 | 3.7% | |
| Q2 2025 | Jun 30, 2025 | — | Aug 12, 2025 | 43 d | 10-Q | — | — | -$0.21 | 0.0% | |
| Q1 2025 | Mar 31, 2025 | — | May 13, 2025 | 43 d | 10-Q | — | — | -$0.35 | 3.3% | |
| FY 2024 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Mar 25, 2025 · after-hours | Mar 25, 2025 | 84 d | 10-K | — | — | — | +3.7% | |
| Q3 2024 | Sep 30, 2024 | Nov 13, 2024 · after-hours | Nov 13, 2024 | 44 d | 10-Q | — | — | -$0.43 | 1.0% | |
| Q2 2024 | Jun 30, 2024 | Aug 13, 2024 · after-hours | Aug 13, 2024 | 44 d | 10-Q | — | — | -$0.48 | 1.0% | |
| Q1 2024 | Mar 31, 2024 | May 14, 2024 · after-hours | May 14, 2024 | 44 d | 10-Q | — | — | -$0.56 | 1.7% | |
| FY 2023 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Mar 28, 2024 · after-hours | Mar 29, 2024 | 89 d | 10-K | — | — | — | +4.6% | |
| Q3 2023 | Sep 30, 2023 | Nov 9, 2023 · after-hours | Nov 9, 2023 | 40 d | 10-Q | — | — | -$0.65 | — | |
| Q2 2023 | Jun 30, 2023 | Aug 10, 2023 · after-hours | Aug 10, 2023 | 41 d | 10-Q | — | — | -$0.81 | +0.4% | |
| Q1 2023 | Mar 31, 2023 | May 11, 2023 · after-hours | May 11, 2023 | 41 d | 10-Q | — | — | -$0.79 | +7.7% | |
| FY 2022 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Mar 29, 2023 · after-hours | Mar 29, 2023 | 88 d | 10-K | — | — | — | 1.9% | |
| Q3 2022 | Sep 30, 2022 | Nov 9, 2022 · after-hours | Nov 9, 2022 | 40 d | 10-Q | — | — | -$0.59 | 6.4% | |
| Q2 2022 | Jun 30, 2022 | Aug 11, 2022 · after-hours | Aug 11, 2022 | 42 d | 10-Q | — | — | -$0.53 | +64.7% | |
| Q1 2022 | Mar 31, 2022 | May 10, 2022 · after-hours | May 10, 2022 | 40 d | 10-Q | — | — | -$2.98 | +14.2% | |
| FY 2021 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | — | — | — | — | — | — | — | — | |
| Q3 2021 | Sep 30, 2021 | — | — | — | — | — | — | -$3.35 | — | |
| Q2 2021 | Jun 30, 2021 | — | — | — | — | — | — | -$2.62 | — | |
| Q1 2021 | Mar 31, 2021 | — | — | — | — | — | — | -$1.07 | — | |
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
The stock’s move from the last close before each release to the first close after it, over the last 12 releases. Largest: −9.3% after Q1 2026.
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.